You are interested in buying shares of Sierra Oncology (SRRA). guide with steps

saw oncology

Sierra Oncology, Inc. researches, develops and markets therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is an orally bioavailable and selective inhibitor of JAK1, JAK2 and ACVR1 that has two completed Phase 3 trials for the treatment of myelofibrosis. The company also develops SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1; and SRA141, an orally bioavailable small molecule inhibitor of cell division cycle 7 kinase. The company was previously known as ProNAi Therapeutics, Inc. and changed its name to Sierra Oncology, Inc. in January 2017. Sierra Oncology, Inc. was incorporated in 2003 and is headquartered in San Mateo, California.

You are interested in buying shares of Sierra Oncology (SRRA). guide with steps

Do you want to buy Sierra Oncology (SRRA) shares on Nasdaq safely and through an officially regulated broker? Would you like to be able to invest your monthly earnings and extract profits on the stock market? With this guide I am going to show you how you can invest in Degiro , a reliable regulated investment broker with very low commissions, and how you can buy your first shares of the company Sierra Oncology, Inc. (SRRA) (SRRA) from fast and intuitive way.

What we will do is simple :

  • First we are going to register in degiro, a platform where we will buy shares of the company Sierra Oncology, Inc. (SRRA) – (SRRA).
  • Then we will enter funds and thus execute the 1st investment in Degiro.
  • As soon as we have the funds, what we’re going to do is search for Sierra Oncology using its TICKER, which is SRRA.
  • To finish we will add the number of shares we want to buy, the price at which we buy and the type of order.

The step by step may have been somewhat simple for you, so I am going to summarize the procedure with images:

Tutorial to register in Degiro.

The first step is to register in DeGiro with the following link :

buy shares of Sierra Oncology, Inc. (SRRA)

It will ask us for an email, a username and a password to access, and later we must continue from the link that they have sent us by e-mail.

Then degiro will ask us for some information of interest in order to approve our document . We need to have in hand the passport, DNI (identity document) or driver’s license, our mobile phone and the bank account number that we are going to use to make our 1st deposit. If you don’t understand how this format works, you can review this simple instruction post that we developed at Educacep .

stock Sierra Oncology

Once our account is validated, we can deposit money from the Deposit/Withdraw tab. We can make a transfer that will take between 1-2 days, or make the deposit instantly using Sofort, a truly secure and very reliable payment gateway.

bank transfer Sierra Oncology

How to buy Sierra Oncology (SRRA) shares through DeGiro

Once we have the money we will be able to get our first share. You can go to the “Place order” button at the top right or use the DEGIRO search engine and put the ticker. In the next screenshot you will see that I have put the Amazon Ticker but you should put (SRRA), the Sierra Oncology ticker. As we are talking about an action, we will see that the related results are listed and there we will discover to find Sierra Oncology. What is key is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Sierra Oncology, Inc. (SRRA) is listed on Nasdaq. This step is important so make no mistake.

american stock exchange schedule Sierra Oncology

When making the order we have to pay special attention to what I am going to explain to you now . We can proceed to place a limit or market order. Think you plan to get a share of Sierra Oncology at 17.42, but its price today is quite high. With a limit order we will adapt the value at which we calculate to make the acquisition and until there are no shares for sale at that value, the purchase operation of the share will not be executed. With a market order, you will buy the number of shares that we have suggested at today’s selling price, which will be very close to today’s trading price.

limited order that is Sierra Oncology, Inc. (SRRA)

In one case or another it is very essential that you look at the order: permanent or of the day . As an example, in Spain, the stock market is from morning until 1 in the afternoon, and in the USA it coincides with the afternoon schedule in Spain. If an order is fixed, it will continue until the moment it reaches execution, but if you select the “of the day” option, at the time the trading day ends, if it has not been executed, it will be deleted from your Activity file – Orders in pending status.

I hope this simple article has helped you to invest in Sierra Oncology. THANK YOU.

  Company information
  • Sierra Oncology, Inc. (SRRA) Address: 1820 Gateway Drive Suite 110 San Mateo, CA 94404 United States 650376 8679 Website:
  • Ticker: SRRA
  • Sector: The sector is unknown
  • Industry: Industry
  • Number of employees: 69
  • Listed market: Nasdaq
  • Value last year: $17.42

company executives

Name Title Payment exercised Year of birth
Dr. Stephen G. Dilly MBBS, Ph.D. President, CEO and Director 778.95 thousand N/A 1960
Dr. Barbara Klencke Chief Develop. Official 706.25k N/A 1957
Dr. Mark M. Kowalski Medical director 629.03k N/A 1955
Mr. Sukhi Jagpal CA, CPA, CBV, MBA CFO N/A N/A 1974
Ms. Christina Thomson MS, JD General Counsel and Sec. Corp. N/A N/A 1971
Mr. William D. Turner Director of technical and regulatory operations N/A N/A 1966
Mr. Kevin Norrett MBA, MS Bus Chief Officer N/A N/A 1973

Recent Sierra Oncology Events:

Recent Events June 11, 2020 Filed Complete 8-K: Submission of Matters to Security Holders Vote June 03, 2020 Filed Complete 8-K: Change of Directors or Principal Officers May 26, 2020 Filed Complete 8-K: Change of Directors or Principal Officers May 07, 2020 Filed Complete 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits May 07, 2020 Filed Complete 10-Q: Quarterly Report